Abstract
Central Hypothyrodism (CeH) is the hypothyroid condition due to an insufficient stimulation by thyrotropin (TSH) of an otherwise normal thyroid gland. CeH is about 1,000-fold more rare than primary hypothyroidism and raises several challenges for the clinicians, mainly because they cannot rely on the systematic use of the “reflex TSH strategy” for diagnosis or therapy monitoring. Therefore, CeH diagnosis is suspected and detectable in patients with known hypothalamic-pituitary diseases, whereas it can be frequently missed in those with a previously unknown pituitary involvement. L-thyroxine replacement in CeH should rely on the combined evaluation of several biochemical and clinical parameters in order to overcome the lack of accuracy of the single index. The management of CeH patients is further complicated by the frequent combination with other pituitary deficiencies and their specific replacement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Persani L (2012) Central hypothyroidism: pathogenic, diagnostic and therapeutic challenges. J Clin Endocrinol Metab 97:3068–3078
Persani L, Beck-Peccoz P (2012) Chapter 38: Central hypothyroidism. In: Braverman LE, Cooper D (eds) Werner & Ingbar’s the thyroid: a fundamental and clinical text, 10th edn. Lippincott Williams & Wilkins/Wolters Kluwer Health, Philadelphia, pp 560–568
Price A, Weetman AP (2001) Screening for central hypothyroidism is unjustified. Br Med J 322:798
Nebesio TD, McKenna MP, Nabhan ZM et al (2010) Newborn screening results in children with central hypothyroidism. J Pediatr 156:990–993
Kempers MJ, Lanting CI, van Heijst AF et al (2006) Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab 91:3370–3376
Miyai K (2007) Congenital thyrotropin deficiency–from discovery to molecular biology, postgenome and preventive medicine. Endocr J 54:191–203
LaFranchi SH (2010) Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab Dis 33(Suppl 2):S225–S233
van Tijn DA, de Vijlder JJ, Vulsma T (2008) Role of the thyrotropin-releasing hormone stimulation test in diagnosis of congenital central hypothyroidism in infants. J Clin Endocrinol Metab 93:410–419
Pfäffle R, Klammt J (2011) Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metab 25:43–60
Raivio T, Avbelj M, McCabe MJ et al (2012) Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin Endocrinol Metab 97:E694–E699
Bonomi M, Proverbio MC, Weber G et al (2001) Hyperplastic pituitary gland, high serum glycoprotein hormone α-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSHβ gene. J Clin Endocrinol Metab 86:1600–1604
Ramos HE, Labedan I, Carré A et al (2010) New cases of isolated congenital central hypothyroidism due to homozygous thyrotropin beta gene mutations: a pitfall to neonatal screening. Thyroid 20:639–645
Collu R, Tang J, Castagnè J et al (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82:1561–1565
Bonomi M, Busnelli M, Beck-Peccoz P et al (2009) A family with complete resistance to thyrotropin-releasing hormone. N Engl J Med 360:731–734
Sun Y, Bak B, Schoenmakers N et al (2012) Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet 44:1375–1381
Joustra SD, Schoenmakers N, Persani L et al (2013) The IGSF1 deficiency syndrome: characteristics of male and female patients. J Clin Endocrinol Metab 98:4942–5492
Ferretti E, Persani L, Jaffrain-Rea ML et al (1999) Evaluation of the adequacy of l-T4 replacement therapy in patients with central hypothyroidism. J Clin Endocrinol Metab 84:924–929
Alexopoulou O, Beguin C, De Nayer P et al (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150:1–8
Rose SR, Lustig RH, Pitukcheewanont P et al (1999) Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84:4472–4479
Darzy KH, Shalet SM (2005) Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J Clin Endocrinol Metab 90:6490–6497
Yamakita N, Komaki T, Takao T et al (2001) Usefulness of thyrotropin (TSH)-releasing hormone test and nocturnal surge of TSH for diagnosis of isolated deficit of TSH secretion. J Clin Endocrinol Metab 86:1054–1060
Faglia G (1998) The clinical impact of the thyrotropin-releasing hormone test. Thyroid 8:903–908
Mehta A, Hindmarsh PC, Stanhope RG et al (2003) Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children? J Clin Endocrinol Metab 88:5696–5703
Andersen S, Pedersen KM, Bruun NH et al (2002) Narrow individual variations in serum T4 and T3 in normal subjects: a clue to understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068–1072
Haugen BR (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23:793–800
Friesema EC, Visser WE, Visser TJ (2010) Genetics and phenomics of thyroid hormone transport by MCT8. Mol Cell Endocrinol 322:107–113
Refetoff S, Bassett JH, Beck-Peccoz P et al (2014) Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. Eur Thyroid J 3:7–9
Bochukova E, Schoenmakers N, Agostini M et al (2012) A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 366:243–249
van Mullem A, van Heerebeek R, Chrysis D (2012) Clinical phenotype and mutant TRα1. N Engl J Med 366:1451–1453
Beck-Peccoz P (2011) Treatment of central hypothyroidism. Clin Endocrinol 74:671–672
Wiersinga WM, Duntas L, Fadeyev V et al (2012) 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J 1:55–71
Hollowell JG, Staehling NW, Flanders WD et al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499
Selva KA, Mandel SH, Rien L (2002) Initial treatment dose of L-thyroxine in congenital hypothyroidism. J Pediatrics 141:786–792
American Academy of Pediatrics, Rose SR; Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown RS; Public Health Committee, Lawson Wilkins Pediatric Endocrine Society, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, Varma SK (2006) Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 117:2290–2303
Koch CA, Sarlis NJ (2001) The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management. J Endocrinol Invest 24:659–675
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Persani, L., Bonomi, M. (2015). Central Hypothyroidism. In: Bona, G., De Luca, F., Monzani, A. (eds) Thyroid Diseases in Childhood. Springer, Cham. https://doi.org/10.1007/978-3-319-19213-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-19213-0_9
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19212-3
Online ISBN: 978-3-319-19213-0
eBook Packages: MedicineMedicine (R0)